Pharmagen, Inc. announced that on June 30, 2014, Richard A. Wolpow resigned as chairman of the board and director; Danny M. Barnes, David S. Rowley and Stephen M. Perry resigned as directors; Boyd P. Relac resigned as chief operating officer and secretary; and Russell Skibsted resigned as executive vice president, chief financial officer and principal financial officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2015 | Pharmagen, Inc. cancelled the transaction announced on November 30, 2012 | CI |
2014 | Pharmagen, Inc. Announces Management Changes | CI |
- Stock Market
- Equities
- PHRX Stock
- News Pharmagen, Inc.
- Pharmagen, Inc. Announces Management Changes